Cardiac protein changes in ischaemic and dilated cardiomyopathy: A proteomic study of human left ventricular tissue

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 10, 2012, Pages 2471-2486

  Roselló Lletí, Esther ^a   Alonso, Jana ^b   Cortés, Raquel ^a   Almenar, Luis ^a   Martínez Dolz, Luis ^a   Sánchez Lázaro, Ignacio ^a   Lago, Francisca ^c   Azorín, Inmaculada ^a   Juanatey, Jose R González ^c   Portolés, Manuel ^a   Rivera, Miguel ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b Santiago University Clinical Hospital   (Spain)

^c Instituto de Salud Carlos III   (Spain)

Author keywords

Dilated; Heart failure; Ischaemic; Proteomics

Indexed keywords

ALPHA CRYSTALLIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE (NADP); HEAT SHOCK PROTEIN 72; PROTEOME;

ADULT; ARTICLE; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; DOWN REGULATION; FEMALE; FLUORESCENCE MICROSCOPY; GENETICS; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE; HUMAN; MALE; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

ADULT; ALPHA-CRYSTALLIN B CHAIN; BLOTTING, WESTERN; CARDIOMYOPATHY, DILATED; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE (NADP+); HEART FAILURE; HEART VENTRICLES; HSP72 HEAT-SHOCK PROTEINS; HUMANS; MALE; MASS SPECTROMETRY; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROTEOME; PROTEOMICS; UP-REGULATION;

EID: 84866753020     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2012.01565.x     Document Type: Article

References (55)

1. Heymes C, Bendall JK, Ratajczak P, et al. Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol. 2003; 41: 2164-71.
2. Cortés R, Roselló-Lletí E, Rivera M, et al. Influence of heart failure on nucleocytoplasmic transport in human cardiomyocytes. Cardiovasc Res. 2009; 85: 464-72.
3. Cortés R, Portolés M, Roselló-Lletí E, et al. Nuclear changes and p62 expression in ischemic and dilated cardiomyopathy. Rev Esp Cardiol. 2007; 60: 1319-23.
4. Knecht M, Regitz-Zagrosek V, Pleissner KP, et al. Characterization of myocardial protein composition in dilated cardiomyopathy by two-dimensional gel electrophoresis. Eur Heart J. 1994; 15: 37-44.
5. Pleissner KP, Regitz-Zagrosek V, Weise C, et al. Chamber-specific expression of human myocardial proteins detected by two-dimensional gel electrophoresis. Electrophoresis. 1995; 16: 841-50.
6. Thiede B, Otto A, Zimny-Arndt U, et al. Identification of human myocardial proteins separated by two-dimensional electrophoresis with matrix-assisted laser desorption/ionization mass spectrometry. Electrophoresis. 1996; 17: 588-99.
7. Corbett JM, Why HJ, Wheeler CH, et al. Cardiac protein abnormalities in dilated cardiomyopathy detected by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis. 1998; 19: 2031-42.
8. Wei YJ, Huang YX, Shen Y, et al. Proteomic analysis reveals significant elevation of heat shock protein 70 in patients with chronic heart failure due to arrhythmogenic right ventricular cardiomyopathy. Mol Cell Biochem. 2009; 332: 103-11.
9. Li W, Rong R, Zhao S, et al. Proteomic analysis of metabolic, cytoskeletal, and stress response proteins in human heart failure. J Cell Mol Med. 2012; 16(1): 59-71. DOI: 10.1111/j.1582-4934.2011.01336.x.
10. Schott P, Asif AR, Gräf C, et al. Myocardial adaptation of energy metabolism to elevated preload depends on calcineurin activity: a proteomic approach. Basic Res Cardiol. 2008; 103: 232-43.
11. Rosca MG, Okere IA, Sharma N, et al. Altered expression of the adenine nucleotide translocase isoforms and decreased ATP synthase activity in skeletal muscle mitochondria in heart failure. J Mol Cell Cardiol. 2009; 46: 927-35.
12. Dohke T, Wada A, Isono T, et al. Proteomic analysis reveals significant alternations of cardiac small heat shock protein expression in congestive heart failure. J Card Fail. 2006; 12: 77-84.
13. Cieniewski-Bernard C, Mulder P, et al. Proteomic analysis of left ventricular remodeling in an experimental model of heart failure. J Proteome Res. 2008; 7: 5004-16.
14. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005; 26: 1115-40.
15. García A, Eiras S, Parguiña AF, et al. High-resolution two-dimensional gel electrophoresis analysis of atrial tissue proteome reveals down-regulation of fibulin-1 in atrial fibrillation. Int J Cardiol. 2010; 150: 283-90.
16. Azorín I, Portolés M, Marín P, et al. Prenatal ethanol exposure alters the cytoskeleton and induces glycoprotein microheterogeneity in rat newborn hepatocytes. Alcohol Alcohol. 2004; 39: 203-12.
17. Hirano M, Davidson M, DiMauro S. Mitochondria and the heart. Curr Opin Cardiol. 2001; 16: 201-10.
18. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998; 281: 1309-12.
19. Kagan VE, Shvedova A, Serbinova E, et al. Dihydrolipoic acid-a universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl and chromanoxyl radicals. Biochem Pharmacol. 1992; 44: 1637-49.
20. Lopez MF, Melov S. Applied proteomics: mitochondrial proteins and effect on function. Circ Res. 2002; 90: 380-9.
21. Taylor SW, Fahy E, Zhang B, et al. Characterization of the human heart mitochondrial proteome. Nat Biotechnol. 2003; 21: 281-6.
22. Mair J. Tissue release of cardiac markers: from physiology to clinical applications. Clin Chem Lab Med. 1999; 37: 1077-84.
23. Ortmann C, Pfeiffer H, Brinkmann B. A comparative study on the immunohistochemical detection of early myocardial damage. Int J Legal Med. 2000; 113: 215-20.
24. Wu AH. Biochemical markers of cardiac damage: from traditional enzymes to cardiac-specific proteins. IFCC Subcommittee on Standardization of Cardiac Markers (S-SCM). Scand J Clin Lab Invest Suppl. 1999; 230: 74-82.
25. Miura T. Does reperfusion induce myocardial necrosis? Circulation. 1990; 82: 1070-2.
26. Flögel U, Gödecke A, Klotz LO, Schrader J. Role of myoglobin in the antioxidant defense of the heart. FASEB J. 2004; 18: 1156-8.
27. Flögel U, Fago A, Rassaf T. Keeping the heart in balance: the functional interactions of myoglobin with nitrogen oxides. J Exp Biol. 2010; 213: 2726-33.
28. Heinke MY, Wheeler CH, Chang D, et al. Protein changes observed in pacing-induced heart failure using two-dimensional electrophoresis. Electrophoresis. 1998; 19: 2021-30.
29. Arrell DK, Neverova I, Van Eyk JE. Cardiovascular proteomics: evolution and potential. Circ Res. 2001; 88: 763-73.
30. Sirover MA. New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta. 1999; 1432: 159-84.
31. Sukhanov S, Higashi Y, Shai SY, et al. Novel effect of oxidized low-density lipoprotein: cellular ATP depletion via downregulation of glyceraldehyde-3-phosphate dehydrogenase. Circ Res. 2006; 99: 191-200.
32. Barbini L, Rodríguez J, Dominguez F, Vega F. Glyceraldehyde-3-phosphate dehydrogenase exerts different biologic activities in apoptotic and proliferating hepatocytes according to its subcellular localization. Mol Cell Biochem. 2007; 300: 19-28.
33. Andrade J, Pearce ST, Zhao H, Barroso M. Interactions among p22, glyceraldehyde-3-phosphate dehydrogenase and microtubules. Biochem J. 2004; 384: 327-36.
34. Nagy E, Rigby WF. Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD(+)-binding region (Rossmann fold). J Biol Chem. 1995; 270: 2755-63.
35. Buse C, Altmann F, Amann B, et al. Discovering novel targets for autoantibodies in dilated cardiomyopathy. Electrophoresis. 2008; 29: 1325-32.
36. Cook SA, Poole-Wilson PA. Cardiac myocyte apoptosis. Eur Heart J. 1999; 20: 1619-29.
37. Keith M, Geranmayegan A, Sole MJ, et al. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol. 1998; 31: 1352-6.
38. Ishitani R, Tanaka M, Sunaga K, et al. Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. Mol Pharmacol. 1998; 53: 701-7.
39. Dastoor Z, Dreyer JL. Potential role of nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase in apoptosis and oxidative stress. J Cell Sci. 2001; 114: 1643-53.
40. Kusner LL, Sarthy VP, Mohr S. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Müller cells. Invest Ophthalmol Vis Sci. 2004; 45: 1553-61.
41. Lu J, Suzuki T, Lu S, Suzuki N. Involvement of glyceraldehyde-3-phosphate dehydrogenase in the X-Ray resistance of HeLa cells. Biosci Biotechnol Biochem. 2008; 72: 2432-5.
42. Mayer MP, Bukau B. Hsp70 chaperone systems: diversity of cellular functions and mechanism of action. Biol Chem. 1998; 379: 261-8.
43. Knowlton AA, Kapadia S, Torre-Amione G, et al. Differential expression of heat shock proteins in normal and failing human hearts. J Mol Cell Cardiol. 1998; 30: 811-8.
44. Barrans JD, Allen PD, Stamatiou D, et al. Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am J Pathol. 2002; 160: 2035-43.
45. Zhu J, Quyyumi AA, Wu H, et al. Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease. Arterioscler Thromb Vasc Biol. 2003; 23: 1055-9.
46. Genth-Zotz S, Bolger AP, Kalra PR, et al. Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival. Int J Cardiol. 2004; 96: 397-401.
47. Currie RW, Tanguay RM, Kingma JG Jr. Heat-shock response and limitation of tissue necrosis during occlusion/reperfusion in rabbit hearts. Circulation. 1993; 87: 963-71.
48. Knowlton AA, Salfity M. Nuclear localization and the heat shock proteins. J Biosci. 1996; 21: 123-32.
49. Sun JZ, Tang XL, Knowlton AA, et al. Late preconditioning against myocardial stunning. An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs. J Clin Invest. 1995; 95: 388-403.
50. Olson TM, Michels VV, Thibodeau SN, et al. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science. 1998; 280: 750-2.
51. Mitchell IJ, Griffiths MR. The differential susceptibility of specific neuronal populations: insights from Huntington's disease. IUBMB Life. 2003; 55: 293-8.
52. Proskuryakov SY, Konoplyannikov AG, Gabai VL. Necrosis: a specific form of programmed cell death? Exp Cell Res. 2003; 283: 1-16.
53. Ray PS, Martin JL, Swanson EA, Otani H, et al. Transgene overexpression of alphaB crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion. FASEB J. 2001; 15: 393-402.
54. Abbate A, Biondi-Zoccai GG, Bussani R, et al. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. J Am Coll Cardiol. 2003; 41: 753-60.
55. Cortés R, Roselló-Lletí E, Rivera M, et al. Expression of B-type natriuretic peptide forms in ischemic human hearts. Int J Cardiol. 2011. DOI: 10.1016/j.ijcard-2011.01.014. [Epub ahead of print].